Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-09

FDA Approved: METHYLPHENIDATE — Supplemental Application (KVK-Tech, Inc.)

View source ↗

Summary

FDA granted supplemental approval for a methylphenidate hydrochloride product developed by KVK-Tech, Inc. This is a routine supplemental approval for a generic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE (METHYLPHENIDATE HYDROCHLORIDE)